Daniela Ferrara appointed by Topcon Healthcare as CMO

News
Article

Topcon Healthcare has appointed Daniela Ferrara, MD, PhD, as chief medical officer to lead the company’s clinical and medical strategy

(Image credit: ©Postmodern Studio/AdobeStock)

(Image credit: ©Postmodern Studio/AdobeStock)

Daniela Ferrara, MD, PhD, is stepping into the role of chief medical officer for Topcon Healthcare, Inc., the company recently announced.1 Topcon Healthcare is recognized as a global leader in digital healthcare solutions and robotic diagnostics.

Leading the company’s clinical and medical strategy, Dr Ferrara will help advance Topcon Healthcare’s Healthcare from the Eye initiative – a connected clinical care model that detects and manages ocular and systemic diseases through the use of artificial intelligent-powered ocular imaging, the press release said.

“The opportunity to combine my scientific passion for retinal imaging with a company that is redefining healthcare through digital innovation is deeply meaningful,” Dr Ferrara said. “I look forward to collaborating with the talented team at Topcon Healthcare."

About Daniela Ferrara, MD, PhD

Daniela Ferrara, MD, PhD, ​Chief Medical Officer. (Image courtesy of Topcon Healthcare, Inc.)

Daniela Ferrara, MD, PhD, Chief Medical Officer. (Image courtesy of Topcon Healthcare, Inc.)

Dr Ferrara comes to Topcon Healthcare from Genentech where she most recently served as Principal Medical Director in Ophthalmology Product Development, leading integration of AI-powered retinal imaging analysis into clinical trials for both biotech and pharma.

“[Dr Ferrara] is a world-renowned physician-scientist with a remarkable track record of advancing ophthalmic innovation through rigorous clinical research, cross-sector leadership, and global collaboration,” said Ali Tafreshi, CEO and president of Topcon Healthcare, in a press release.

“Her clinical insight and deep understanding of drug and device development anchored on medical imaging make her uniquely suited to guide the next generation of AI-powered solutions for early disease detection and the potential for more comprehensive, holistic clinical care.”

Dr Ferrara’s career has also included leadership roles in various spaces: clinical development, personalized healthcare, and global strategic initiatives; as well as contributions to the development of transformative retinal therapies.

She holds an MD from the Federal University of Rio de Janeiro and a PhD in Visual Sciences from the University of Sao Paulo. Her qualifications also include authoring numerous peer-reviewed publications, serving on editorial boards of leading journals, and holding committee roles in global ophthalmic societies.

Reference
1. Topcon Healthcare, Inc. Appoints Daniela Ferrara, MD, PhD, to the role of Chief Medical Officer. Topcon Healthcare. https://topconhealthcare.com/article/topcon-healthcare-inc-appoints-daniela-ferrara-md-phd-to-the-role-of-chief-medical-officer/. Published April 28, 2025.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
© 2025 MJH Life Sciences

All rights reserved.